Time-dependent protection of CB2 receptor agonist in stroke

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Yu, Seong Jin ^a   Reiner, David ^b   Shen, Hui ^b   Wu, Kou Jen ^a   Liu, Qing Rong ^b   Wang, Yun ^a,b  

^a Center for Neuropsychiatric Research   (Taiwan)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; BRAIN PROTEIN; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PROTEIN IBA1; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACTIN BINDING PROTEIN; AIF1 PROTEIN, RAT; CALCIUM BINDING PROTEIN; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; GLUTAMIC ACID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EMBRYO; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; RECEPTOR UPREGULATION; SCORING SYSTEM; THERAPY DELAY; TREATMENT FAILURE; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; BRAIN CORTEX; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; SPRAGUE DAWLEY RAT; STROKE; TIME FACTOR;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CALCIUM-BINDING PROTEINS; CANNABINOID RECEPTOR AGONISTS; CANNABINOIDS; CEREBRAL CORTEX; GLUTAMIC ACID; MALE; MICROFILAMENT PROTEINS; NERVE DEGENERATION; NEURONS; NEUROPROTECTION; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; STROKE; THIAZOLIDINEDIONES; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84940881400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132487     Document Type: Article

References (44)

1. Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A, et al. (1996) Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci 58: 1239-1247. 0024320596000859 [pii]. PMID: 8614277.
2. Gatley SJ, Gifford AN, Volkow ND, Lan R, Makriyannis A (1996) 123I-labeled AM251: A radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 307: 331-338. 0014299996002798 [pii]. PMID: 8836622.
3. Lynn AB, Herkenham M (1994) Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268: 1612-1623. PMID: 8138973.
4. Brusco A, Tagliaferro PA, Saez T, Onaivi ES (2008) Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci 1139: 450-457. NYAS1139037 [pii]; doi:10.1196/annals.1432.037 PMID: 18991892.
5. Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR, et al. (2011) Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice. Nat Neurosci 14: 1160-1166. nn.2874 [pii]; doi:10.1038/nn.2874 PMID: 21785434.
6. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071: 10-23. S0006-8993(05) 01623-9 [pii]; doi:10.1016/j.brainres.2005.11.035 PMID: 16472786.
7. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, et al. (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074: 514-536. 1074/1/514 [pii]; doi:10.1196/annals.1369.052 PMID: 17105950.
8. Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, et al. (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study. Synapse 53: 208-213. doi:10.1002/syn.20050 PMID: 15266552.
9. Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95: 437-445. JNC3380 [pii]; doi:10.1111/j.1471-4159.2005.03380.x PMID: 16086683.
10. Capettini LS, Savergnini SQ, da Silva RF, Stergiopulos N, Santos RA, Mach F, et al. (2012) Update on the role of cannabinoid receptors after ischemic stroke. Mediators Inflamm 2012: 824093. doi:10.1155/2012/824093 PMID: 22577257.
11. Sidney S (2002) Cardiovascular consequences of marijuana use. J Clin Pharmacol 42: 64S-70S. PMID: 12412838.
12. Hayakawa K, Mishima K, Nozako M, Hazekawa M, Ogata A, Fujioka M, et al. (2007) Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia. Life Sci 80: 1466-1471. S0024-3205(07)00063-X [pii]; doi:10.1016/j.lfs.2007.01.014 PMID: 17289082.
13. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19: 2987-2995. PMID: 10191316.
14. Jin KL, Mao XO, Goldsmith PC, Greenberg DA (2000) CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol 48: 257-261. PMID: 10939579.
15. Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, Garcia-Gutierrez MS, Vivancos J, Nombela F, et al. (2012) Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 43: 211-219. STROKEAHA. 111.631044 [pii]; doi:10.1161/STROKEAHA.111.631044 PMID: 22020035.
16. Fernandez-Lopez D, Faustino J, Derugin N, Wendland M, Lizasoain I, Moro MA, et al. (2012) Reduced infarct size and accumulation of microglia in rats treated with WIN 55, 212-2 after neonatal stroke. Neuroscience 207: 307-315. S0306-4522(12)00030-9 [pii]; doi:10.1016/j.neuroscience.2012.01.008 PMID: 22285309.
17. Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 22: 9771-9775. 22/22/9771 [pii]. PMID: 12427832.
18. Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ (2004) Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience 129: 743-750. S0306-4522(04)00768-7 [pii]; doi:10.1016/j.neuroscience.2004.08.044 PMID: 15541895.
19. Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95: 437-445. JNC3380 [pii]; doi:10.1111/j.1471-4159.2005.03380.x PMID: 16086683.
20. Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, et al. (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 132: 3152-3164. awp239 [pii]; doi:10.1093/brain/awp239 PMID: 19805493.
21. Elliott MB, Tuma RF, Amenta PS, Barbe MF, Jallo JI (2011) Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J Neurotrauma 28: 973-981. doi:10.1089/neu.2010.1672 PMID: 21332427.
22. Ternianov A, Perez-Ortiz JM, Solesio ME, Garcia-Gutierrez MS, Ortega-Alvaro A, Navarrete F, et al. (2012) Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. Neurobiol Aging 33: 421-16. S0197-4580(10)00392-1 [pii]; doi:10.1016/j.neurobiolaging.2010.09.012.
23. Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF (2007) Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab 27: 1387-1396. 9600447 [pii]; doi:10.1038/sj.jcbfm.9600447 PMID: 17245417.
24. Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, et al. (2009) The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis 33: 57-71. S0969-9961(08)00225-8 [pii]; doi:10.1016/j.nbd.2008.09.015 PMID: 18930143.
25. Contartese A, Valoti M, Corelli F, Pasquini S, Mugnaini C, Pessina F, et al. (2012) A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury. Pharmacol Res 66: 555-563. S1043-6618(12)00163-6 [pii]; doi:10.1016/j.phrs.2012.08.003 PMID: 23036353.
26. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, et al. (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A 106: 20388-20393. 0908698106 [pii]; doi:10.1073/pnas.0908698106 PMID: 19918053.
27. Luo Y, Shen H, Liu HS, Yu SJ, Reiner DJ, Harvey BK, et al. (2013) CART peptide induces neuroregeneration in stroke rats. J Cereb Blood Flow Metab 33: 300-310. jcbfm2012172 [pii]; doi:10.1038/jcbfm.2012.172 PMID: 23211962.
28. Luo Y, Kuo CC, Shen H, Chou J, Greig NH, Hoffer BJ, et al. (2009) Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol 65: 520-530. doi:10.1002/ana.21592 PMID: 19475672.
29. Liu HS, Shen H, Harvey BK, Castillo P, Lu H, Yang Y, et al. (2011) Post-treatment with amphetamine enhances reinnervation of the ipsilateral side cortex in stroke rats. Neuroimage 56: 280-289. S1053- 8119(11)00205-9 [pii]; doi:10.1016/j.neuroimage.2011.02.049 PMID: 21349337.
30. Tumati S, Largent-Milnes TM, Keresztes A, Ren J, Roeske WR, Vanderah TW, et al. (2012) Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by coadministration of a selective cannabinoid receptor type-2 agonist. J Neuroimmunol 244: 23-31. S0165-5728(11)00373-0 [pii]; doi:10.1016/j.jneuroim.2011.12.021 PMID: 22285397.
31. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE (2005) Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130: 685-696. S0306-4522(04)00957-1 [pii]; doi:10.1016/j.neuroscience.2004.10.021 PMID: 15590152.
32. Borlongan CV, Sanberg PR (1995) Elevated body swing test: A new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J Neurosci 15: 5372-5378. PMID: 7623159.
33. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17: 472-476. PMID: 3715945.
34. Shen H, Wang Y (2010) Correlation of locomotor activity and brain infarction in rats with transient focal ischemia. J Neurosci Methods 182: 150-154.
35. Borlongan CV, Hida H, Nishino H (1998) Early assessment of motor dysfunctions AIDS in successful occlusion of the middle cerebral artery. Neuroreport 9: 3615-3621. PMID: 9858369.
36. Chang CF, Morales M, Chou J, Chen HL, Hoffer BJ, Wang Y (2002) Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats. Neuropharmacology 43: 418-426. PMID: 12243771.
37. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100: 8514-8519. doi:10.1073/pnas.1432609100 1432609100 [pii]. PMID: 12824464.
38. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115: 1599-1608. CIRCULATIONAHA.106.603431 [pii]; doi:10.1161/CIRCULATIONAHA.106.603431 PMID: 17372179.
39. Bingham B, Jones PG, Uveges AJ, Kotnis S, Lu P, Smith VA, et al. (2007) Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br J Pharmacol 151: 1061-1070. 0707303 [pii]; doi:10.1038/sj.bjp.0707303 PMID: 17549048.
40. Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Kuhn MN, et al. (2012) Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal antiinflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain Behav 2: 155-177. doi:10.1002/brb3.44 PMID: 22574283.
41. Malan TP Jr., Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T, et al. (2001) CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93: 239-245. S0304395901003219[pii]. PMID: 11514083.
42. Wei Y, Wang X, Wang L (2009) Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. Mol Vis 15: 1243-1251. 132 [pii]. PMID: 19547718.
43. Assis LC, Straliotto MR, Engel D, Hort MA, Dutra RC, de Bem AF (2014) beta-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway. Neuroscience 279: 220-231. S0306-4522(14)00721-0 [pii]; doi:10.1016/j.neuroscience.2014.08.043 PMID: 25194788.
44. Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF (2009) CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc Res 78: 86-94. S0026-2862(09)00087-9 [pii]; doi:10.1016/j.mvr.2009.03.005 PMID: 19332079.